(GSLC) Goldman Sachs ActiveBeta - Ratings and Ratios

Exchange: NYSE ARCA • Country: USA • Currency: USD • Type: Etf • ISIN: US3814305039 • Large Blend

GSLC: Stocks, Equity, Securities

Goldman Sachs ActiveBeta® U.S. Large Cap Equity ETF (GSLC) offers a strategic approach to large-cap U.S. equities, utilizing a unique ActiveBeta strategy to enhance returns while maintaining a risk profile similar to traditional capitalization-weighted indexes. This ETF is designed for investors seeking exposure to large-cap U.S. companies, which are typically more stable and have established market positions compared to smaller-cap firms.

GSLC invests at least 80% of its assets in securities from its underlying index, which includes depositary receipts and the underlying stocks these receipts represent. This structure allows the fund to maintain diversification while aligning with the performance of the U.S. large-cap market. The ETFs focus on large-cap companies provides exposure to sectors that are significant to the U.S. economy, such as technology, healthcare, and financials.

As a large blend ETF, GSLC combines elements of both growth and value investing, appealing to investors who want a balanced exposure to large-cap equities without a strong bias towards either style. The funds expense ratio and tracking error are designed to be competitive, making it a cost-effective option for those seeking large-cap equity exposure with the potential for enhanced returns through the ActiveBeta approach.

GSLC is listed on the NYSE ARCA under the ticker symbol GSLC, with a market capitalization of approximately $13.6 billion. This substantial size indicates a high level of investor confidence and liquidity, making it easier for investors to buy and sell shares without significantly impacting the price. The funds domicile in the United States ensures compliance with U.S. regulatory standards, providing an additional layer of investor protection and transparency.

For fund managers and institutional investors, GSLCs structure and investment strategy offer a tool to gain efficient exposure to the U.S. large-cap market. Its ActiveBeta approach aims to optimize returns by incorporating alternative weighting strategies, potentially leading to better risk-adjusted performance compared to traditional market-cap weighted indexes. This makes GSLC a valuable component in a diversified investment portfolio, particularly for those seeking to balance risk and return in the large-cap equity space.

Additional Sources for GSLC ETF

GSLC ETF Overview

Market Cap in USD 12,370m
Category Large Blend
TER 0.09%
IPO / Inception 2015-09-17

GSLC ETF Ratings

Growth 5y 82.2%
Fundamental -
Dividend 57.8%
Rel. Strength -0.8
Analysts -
Fair Price Momentum 106.90 USD
Fair Price DCF -

GSLC Dividends

Dividend Yield 12m 0.88%
Yield on Cost 5y 1.94%
Annual Growth 5y 10.45%
Payout Consistency 97.0%

GSLC Growth Ratios

Growth Correlation 3m -50.2%
Growth Correlation 12m 85.2%
Growth Correlation 5y 82.6%
CAGR 5y 16.97%
CAGR/Max DD 5y 0.68
Sharpe Ratio 12m 1.40
Alpha -0.93
Beta 0.990
Volatility 18.86%
Current Volume 493.8k
Average Volume 20d 270.7k
What is the price of GSLC stocks?
As of March 31, 2025, the stock is trading at USD 109.38 with a total of 493,779 shares traded.
Over the past week, the price has changed by -3.04%, over one month by -4.78%, over three months by -5.10% and over the past year by +6.91%.
Is Goldman Sachs ActiveBeta a good stock to buy?
Yes. Based on ValueRay Analyses, Goldman Sachs ActiveBeta (NYSE ARCA:GSLC) is currently (March 2025) a good stock to buy. It has a ValueRay Growth Rating of 82.23 and therefor a clear technical positive rating according to historical growth.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of GSLC as of March 2025 is 106.90. This means that GSLC is currently overvalued and has a potential downside of -2.27%.
Is GSLC a buy, sell or hold?
Goldman Sachs ActiveBeta has no consensus analysts rating.
What are the forecast for GSLC stock price target?
According to ValueRays Forecast Model, GSLC Goldman Sachs ActiveBeta will be worth about 118.8 in March 2026. The stock is currently trading at 109.38. This means that the stock has a potential upside of +8.64%.
Issuer Forecast Upside
Wallstreet Target Price - -
Analysts Target Price - -
ValueRay Target Price 118.8 8.6%